Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
India and the US are on the verge of a trade agreement that will transform commerce between the two largest …
Post
-
-
Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients …
-
Orion and Glykos extend ADC collaboration
Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs). Under the research partnership and …
-
FDA creates new priority review voucher scheme to boost US interests
The US Food and Drug Administration (FDA) has created a new priority review voucher (PRV) framework to expedite the drug …
-
Lisata collaborates with GATC Health on drug development
Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development. The collaboration aims to …
-
Genomics to roll out predictive clinical test across UK
Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent …
-
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn, with …
-
AI-powered orchestration: Bringing the benefits to personalized therapy
Cell and gene therapies represent a groundbreaking advancement in medical science, offering transformative opportunities for treating complex and previously untreatable …
-
European pharma needs scalable models to succeed in US
European companies must be able to provide developed and scalable business models if they want to enter the US to …
-
Averoa secures EC authorisation for oral CKD treatment
The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney disease (CKD), a condition …
-
European biotech ecosystem takes aim at changing the funding narrative
“The science is brilliant in Europe, but the translation is what’s lacking,” said V-Bio Ventures managing partner Christina Takke on …
-
Ex-ACIP panel warns of ‘critically weakened’ US immunisation programme
Sweeping changes made by US health secretary Robert F Kennedy, Jr (RFK Jr) at the Centers for Disease Control and …
-
Teva to collaborate with Fosun Pharma for TEV-56278
Teva Pharmaceutical has announced a collaboration with Shanghai Fosun Pharmaceutical (Fosun Pharma) to advance the global development of the anti-programmed …
-
NextCure and Simcere partner to develop SIM0505 for solid tumours
NextCure has entered a strategic partnership with Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, to develop SIM0505, a new …
-
Supernus makes depression drug play with $795m Sage buyout
Fewer than five months after rejecting a takeover approach by Biogen, Sage Therapeutics has found a buyer in Supernus Pharmaceuticals. According …
